Insider Transactions in Q1 2024 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,098
-5.1%
|
$0
$0.68 P/Share
|
|
Mar 31
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,952
+12.85%
|
-
|
|
Mar 31
2024
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,172
-4.14%
|
$0
$0.68 P/Share
|
|
Mar 31
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,474
+12.37%
|
-
|
|
Mar 31
2024
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,082
-7.48%
|
$0
$0.68 P/Share
|
|
Mar 31
2024
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,956
+15.43%
|
-
|
|
Jan 01
2024
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,327
-1.54%
|
$0
$0.34 P/Share
|
|
Jan 01
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,724
+4.26%
|
-
|
|
Jan 01
2024
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-1.12%
|
$0
$0.34 P/Share
|
|
Jan 01
2024
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,231
+2.66%
|
-
|